Skip to main content

Everolimus

NDC 0054-0472 · Hikma Pharmaceuticals USA Inc.

Generic nameEverolimus
Dosage formTABLET
RouteORAL
Active ingredient(s)EVEROLIMUS
Strength.75 mg/1
Pharmacologic classCytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]
Marketing categoryANDA

Packages

0054-0472-21 — 60 TABLET in 1 BOTTLE (0054-0472-21)

Billed under HCPCS

J7527 — Everolimus, oral, 0.25 mg Medicare Part B payment limit (ASP + 6%): $1.13

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0054-0470 — Everolimus, 0054-0471 — Everolimus, 0054-0480 — Everolimus, 0054-0481 — Everolimus, 0054-0482 — Everolimus, 0054-0497 — Everolimus, 0054-0604 — Everolimus, 0078-0414 — everolimus, 0078-0415 — everolimus, 0078-0417 — everolimus, 0078-0422 — everolimus, 0078-0566 — everolimus, 0078-0567 — everolimus, 0078-0594 — everolimus, 0078-0620 — everolimus, 0078-0626 — everolimus, 0078-0627 — everolimus, 0078-0628 — everolimus, 0093-7766 — Everolimus, 0093-7767 — Everolimus, +63 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q4 (October 2026 release). All data sources · How to read the labels

Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 28, 2026 · All releases and sources